Kames Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$146M |
| 2 |
AbbVie
ABBV
|
+$67.4M |
| 3 |
Walt Disney
DIS
|
+$47.7M |
| 4 |
Qualcomm
QCOM
|
+$47.1M |
| 5 |
Gilead Sciences
GILD
|
+$41.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$76.2M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$32.7M |
| 3 |
Amgen
AMGN
|
+$27.4M |
| 4 |
Chevron
CVX
|
+$24.6M |
| 5 |
Monster Beverage
MNST
|
+$23.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.09% |
| 2 | Technology | 15.06% |
| 3 | Communication Services | 14.23% |
| 4 | Industrials | 12.04% |
| 5 | Financials | 11.25% |
Similar funds
Kames Capital Management's Q1 2014 Portfolio in Review
As of Q1 2014, Kames Capital Management held 191 positions worth $3.16B, up 5.2% from $3.01B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Kames Capital Management deployed $121M of net new capital in Q1 2014, opening 26 new positions and adding to 33 existing holdings. Its largest new stake was Coterra Energy: 623,565 shares worth $21.1M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Pfizer, an estimated $76.2M trimmed.
- Kames Capital Management's largest Q1 2014 buy was Coterra Energy: 623,565 shares worth $21.1M.
- Kames Capital Management added most to Verizon in Q1 2014, an estimated $146M increase.
- Kames Capital Management's biggest Q1 2014 reduction was Pfizer, cutting an estimated $76.2M.
- Kames Capital Management fully exited Time Warner Inc in Q1 2014, selling an estimated $32.7M.
- Kames Capital Management's ten largest holdings make up 31% of its $3.16B portfolio in Q1 2014.
- Kames Capital Management opened 26 new positions and closed 26 in Q1 2014.
- Kames Capital Management's portfolio value rose 5.2% quarter-over-quarter to $3.16B.
Based on Kames Capital Management's 13F filing for Q1 2014, filed 1 May 2014.